Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1141 ARTÍCULOS , VIENDO DEL 136 AL 150

Cholinesterase inhibitors in vascular cognitive impairment

Massoud F.

Can J Neurol Sci. 2013 Jul;40(4):446-7. doi: 10.1017/s0317167100014487.

[Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease]

Mal'tsev AV, Davidchenko NV, Uteshev VK, Sokolik VV, Shtang OM, Iakushun MA, Sokolova NM, Suprin AK, Galzitskaia OV.

Biomed Khim. 2013 Mar-Apr;59(2):144-70. doi: 10.18097/pbmc20135902144.

γ-Secretase inhibitors and modulators

Golde TE, Koo EH, Felsenstein KM, Osborne BA, Miele L.

Biochim Biophys Acta. 2013 Dec;1828(12):2898-907. doi: 10.1016/j.bbamem.2013.06.005. Epub 2013 Jun 17.

Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

Ashby EL, Kehoe PG.

Expert Opin Investig Drugs. 2013 Oct;22(10):1229-42. doi: 10.1517/13543784.2013.812631. Epub 2013 Jun 26.

Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms?

Corbett A, Ballard C.

Expert Opin Investig Drugs. 2013 Aug;22(8):941-3. doi: 10.1517/13543784.2013.815723. Epub 2013 Jul 1.

New and different approaches needed for the design and execution of Alzheimer's clinical trials

Carrillo MC, Vellas B.

Alzheimers Dement. 2013 Jul;9(4):436-7. doi: 10.1016/j.jalz.2013.03.008.

Caregiver burden and psychosocial services in patients with early and late onset Alzheimer's disease

Grønning H, Kristiansen S, Dyre D, Rahmani A, Gyllenborg J, Høgh P.

Dan Med J. 2013 Jul;60(7):A4649.

Coping with dementia in care homes

Corbett A, Nunez K, Thomas A.

Maturitas. 2013 Sep;76(1):3-4. doi: 10.1016/j.maturitas.2013.06.002. Epub 2013 Jun 28.

Sorting receptor SORLA--a trafficking path to avoid Alzheimer disease

Willnow TE, Andersen OM.

J Cell Sci. 2013 Jul 1;126(Pt 13):2751-60. doi: 10.1242/jcs.125393. Epub 2013 Jun 26.

[Validity of complex figure test in differentiation of Alzheimer's disease from non-dementia]

Hong X, Zhang ZX, Wu LY, Shi LL, Zhao XH, Wei J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Jun;35(3):348-52. doi: 10.3881/j.issn.1000-503X.2013.03.020.

Mens sana in corpore sano revisited

Jeger RV.

Eur Heart J. 2013 Sep;34(33):2580-1. doi: 10.1093/eurheartj/eht244. Epub 2013 Jul 4.

The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer's disease

Jayasena T, Poljak A, Smythe G, Braidy N, Münch G, Sachdev P.

Ageing Res Rev. 2013 Sep;12(4):867-83. doi: 10.1016/j.arr.2013.06.003. Epub 2013 Jul 5.

Reversing heart failure by CRT: how long do the effects last?

Breithardt OA.

Eur Heart J. 2013 Sep;34(33):2582-4. doi: 10.1093/eurheartj/eht238. Epub 2013 Jul 4.

Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease

Snellman A, López-Picón FR, Rokka J, Salmona M, Forloni G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M.

J Nucl Med. 2013 Aug;54(8):1434-41. doi: 10.2967/jnumed.112.110163. Epub 2013 Jul 5.

A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol

Weinstein JD, Gonzalez ER, Egleton RD, Hunt DA.

Consult Pharm. 2013 Jul;28(7):443-54. doi: 10.4140/TCP.n.2013.443.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias